Citigroup’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-56,500
| Closed | -$6.52M | – | 7826 |
|
|
2020
Q4 | $6.52M | Buy |
56,500
+32,500
| +135% | +$3.64M | ﹤0.01% | 1883 |
|
|
2020
Q3 | $2.34M | Buy |
24,000
+2,400
| +11% | +$276K | ﹤0.01% | 2512 |
|
|
2020
Q2 | $2.65M | Sell |
21,600
-30,900
| -59% | -$3.51M | ﹤0.01% | 2479 |
|
|
2020
Q1 | $4.6M | Sell |
52,500
-7,500
| -13% | -$794K | ﹤0.01% | 1747 |
|
|
2019
Q4 | $6.27M | Sell |
60,000
-8,200
| -12% | -$919K | ﹤0.01% | 1843 |
|
|
2019
Q3 | $7.84M | Buy |
68,200
+44,400
| +187% | +$6.74M | 0.01% | 1577 |
|
|
2019
Q2 | $4.1M | Buy |
23,800
+6,300
| +36% | +$1.09M | ﹤0.01% | 2140 |
|
|
2019
Q1 | $2.95M | Sell |
17,500
-20,800
| -54% | -$3.1M | ﹤0.01% | 2240 |
|
|
2018
Q4 | $3.73M | Sell |
38,300
-11,600
| -23% | -$1.52M | ﹤0.01% | 2093 |
|
|
2018
Q3 | $8.62M | Buy |
49,900
+28,200
| +130% | +$4.07M | 0.01% | 1391 |
|
|
2018
Q2 | $3.03M | Sell |
21,700
-12,600
| -37% | -$1.79M | ﹤0.01% | 2312 |
|
|
2018
Q1 | $3.87M | Buy |
34,300
+2,200
| +7% | +$277K | ﹤0.01% | 2005 |
|
|
2017
Q4 | $4.24M | Buy |
32,100
+8,600
| +37% | +$1.01M | ﹤0.01% | 1989 |
|
|
2017
Q3 | $2.38M | Buy |
23,500
+2,500
| +12% | +$268K | ﹤0.01% | 2474 |
|
|
2017
Q2 | $2.1M | Sell |
21,000
-73,900
| -78% | -$7.95M | ﹤0.01% | 2540 |
|
|
2017
Q1 | $11.5M | Buy |
94,900
+5,900
| +7% | +$724K | 0.01% | 1047 |
|
|
2016
Q4 | $9.95M | Buy |
89,000
+39,800
| +81% | +$4.79M | 0.01% | 1200 |
|
|
2016
Q3 | $6.53M | Sell |
49,200
-39,600
| -45% | -$3.78M | 0.01% | 1428 |
|
|
2016
Q2 | $8.13M | Buy |
88,800
+22,800
| +35% | +$1.92M | 0.01% | 1181 |
|
|
2016
Q1 | $4.76M | Buy |
66,000
+21,600
| +49% | +$1.19M | 0.01% | 1600 |
|
|
2015
Q4 | $3.08M | Buy |
44,400
+25,800
| +139% | +$2.1M | ﹤0.01% | 2134 |
|
|
2015
Q3 | $1.7M | Buy |
18,600
+6,900
| +59% | +$767K | ﹤0.01% | 2607 |
|
|
2015
Q2 | $1.44M | Buy |
11,700
+2,200
| +23% | +$250K | ﹤0.01% | 2845 |
|
|
2015
Q1 | $866K | Buy |
+9,500
| New | +$771K | ﹤0.01% | 3228 |
|
Other funds holding GWPH
Citigroup's GWPH Position: Q2 2021 in Review
Citigroup sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 73,319 shares — an estimated $15.9M sold.
Citigroup first reported a position in GWPH in Q4 2013 and held it in 30 quarters. The position peaked at $15.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Citigroup reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Citigroup sold 73,319 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $15.9M.
- Citigroup first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 30 quarters.
- Citigroup's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15.9M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.